Morris Capital Advisors, LLC Abb Vie Inc. Transaction History

Morris Capital Advisors, LLC

$106 Million
Q3 2022

A detailed history of Morris Capital Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Morris Capital Advisors, LLC holds 23,565 shares of ABBV stock, worth $3.89 Million. This represents 2.98% of its overall portfolio holdings.

Number of Shares

23,565

Previous 23,814 1.05%

Holding current value

$3.89 Million

Previous $3.65 Million 13.27%

% of portfolio

2.98%

Previous 3.25%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 26, 2022	SELL	$134.21 - $153.93 $33,418 - $38,328	-249 Reduced 1.05%	23,565 $3.16 Million
Q2 2022 Jul 15, 2022	BUY	$137.62 - $174.96 $24,221 - $30,792	176 Added 0.74%	23,814 $3.65 Million
Q1 2022 May 09, 2022	SELL	$131.98 - $163.75 $71,797 - $89,080	-544 Reduced 2.25%	23,638 $3.83 Million
Q4 2021 Feb 09, 2022	SELL	$107.43 - $135.93 $136,650 - $172,902	-1,272 Reduced 5.0%	24,182 $3.27 Million
Q3 2021 Oct 22, 2021	SELL	$106.4 - $120.78 $113,316 - $128,630	-1,065 Reduced 4.02%	25,454 $2.75 Million
Q2 2021 Jul 15, 2021	SELL	$105.21 - $117.21 $3,997 - $4,453	-38 Reduced 0.14%	26,519 $2.99 Million
Q1 2021 Apr 16, 2021	SELL	$102.3 - $112.62 $83,988 - $92,461	-821 Reduced 3.0%	26,557 $2.87 Million
Q4 2020 Jan 19, 2021	BUY	$80.49 - $108.67 $196,637 - $265,480	2,443 Added 9.8%	27,378 $2.93 Million
Q3 2020 Oct 19, 2020	SELL	$85.91 - $100.83 $131,871 - $154,774	-1,535 Reduced 5.8%	24,935 $2.18 Million
Q2 2020 Jul 23, 2020	BUY	$73.37 - $98.18 $107,340 - $143,637	1,463 Added 5.85%	26,470 $2.6 Million
Q1 2020 May 07, 2020	BUY	$64.5 - $97.79 $112,230 - $170,154	1,740 Added 7.48%	25,007 $1.91 Million
Q4 2019 Jan 31, 2020	SELL	$72.13 - $90.25 $380,269 - $475,798	-5,272 Reduced 18.47%	23,267 $2.06 Million
Q3 2019 Oct 21, 2019	SELL	$62.98 - $75.72 $149,640 - $179,910	-2,376 Reduced 7.69%	28,539 $2.16 Million
Q2 2019 Jul 15, 2019	SELL	$65.7 - $83.98 $399,390 - $510,514	-6,079 Reduced 16.43%	30,915 $2.25 Million
Q1 2019 Apr 29, 2019	SELL	$77.14 - $90.79 $35,098 - $41,309	-455 Reduced 1.21%	36,994 $2.98 Million
Q4 2018 Feb 20, 2019	SELL	$77.85 - $96.01 $185,983 - $229,367	-2,389 Reduced 6.0%	37,449 $3.45 Million
Q3 2018 Oct 31, 2018	SELL	$88.91 - $98.84 $42,054 - $46,751	-473 Reduced 1.17%	39,838 $3.77 Million
Q2 2018 Aug 13, 2018	BUY	$89.78 - $106.23 $1.59 Million - $1.88 Million	17,716 Added 78.41%	40,311 $3.74 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $5,612 - $7,515	-61 Reduced 0.27%	22,595 $2.14 Million
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $66,005 - $72,380	-737 Reduced 3.15%	22,656 $2.19 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $1.63 Million - $2.09 Million	23,393	23,393 $2.08 Million

Others Institutions Holding ABBV

# of Institutions

3,841

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $292B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morris Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Morris Capital Advisors, LLC with notifications on news.

Account

Morris Capital Advisors, LLC Abb Vie Inc. Transaction History